Provepharm Life Solutions SA announced that it has received €120 million in a round of funding on September 8, 2021. The transaction included participation from new investor Tikehau Capital, returning investors including Société Générale Capital Partenaires SAS, SCR, BNP Paribas Développement SA, SCR, Banque Populaire Mediterranee, CAAP Création and Bpifrance Investissement SAS.